Nef stabilizes actin to prevent HIV-1 sensing by RIG-I-like receptors
Sensing of viral pathogens by RIG-I-like receptors (RLRs) requires their priming via dephosphorylation mediated by the protein phosphatase 1 regulatory subunit 12 C (R12C), which is activated upon virus-induced actin rearrangements. Here, we show that the HIV-1 accessory protein Nef prevents R12C-mediated RLR priming, thereby suppressing viral sensing. HIV-1 variants containing single point mutations in Nef (F/R191A) that ablate its ability to bind the actin-modulating kinase PAK2 trigger increased interferon (IFN) responses in primary CD4<sup>+</sup> T cells, macrophages, and dendritic cells. Neutralization of IFN suppresses innate immune activation and enhances the replication of Nef-mutated HIV-1. We further demonstrate that HIV-1 encoding Nef F/R191A is sensed by MDA5 after proviral integration in an R12C-dependent manner. Mechanistically, PAK2 binding by Nef promotes actin repair and stabilization, thereby preventing re-localization of R12C to MDA5 and RIG-I and their subsequent dephosphorylation. Our data identify Nef as an antagonist of actin-R12C-mediated RLR priming, enabling HIV-1 to escape immune control.
Authors
- Alexandre Laliberté (ORCID: https://orcid.org/0000-0002-6526-4133)
- O. Fackler (ORCID: https://orcid.org/0000-0003-2982-4209)
- Aurora De Luna (ORCID: https://orcid.org/0009-0008-0214-4872)
- Michaela U. Gack (ORCID: https://orcid.org/0000-0002-2163-2598)
- Meta Volčič (ORCID: https://orcid.org/0000-0001-6406-7683)
- Dhiraj Acharya (ORCID: https://orcid.org/0000-0003-1929-3870)
- Bettina Stolp (ORCID: https://orcid.org/0000-0003-2945-8536)
- Konstantin M. J. Sparrer (ORCID: https://orcid.org/0000-0002-8682-1779)
- Maximilian Hirschenberger (ORCID: https://orcid.org/0000-0001-8766-1271)
- Junji Zhu (ORCID: https://orcid.org/0000-0003-2968-180X)
- Caterina Prelli Bozzo (ORCID: https://orcid.org/0009-0000-2763-102X)
- Frank Kirchhoff (ORCID: https://orcid.org/0000-0002-7052-2360)
- Cristina Marcela Rodriguez-Quinteros
Institutions
- Cleveland Clinic (US)
- Universität Ulm (DE)
- Heidelberg University (DE)
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Heidelberg (DE)
- Yale University (US)
- German Center for Infection Research (DE)
- Heidelberg University (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-12-07
- DOI
- https://doi.org/10.1038/s41467-025-67028-5
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00